Literature DB >> 19388614

Femoral neck fractures: evidence versus beliefs about predictors of outcome.

Michael Zlowodzki1, Paul Tornetta, George Haidukewych, Beate P Hanson, Brad Petrisor, Marc F Swiontkowski, Emil H Schemitsch, Peter V Giannoudis, Mohit Bhandari.   

Abstract

It is unclear whether current practice reflects current evidence on predictors of clinically important outcomes like mortality and fixation failure. Knowledge of predictors of outcome can and should influence treatment decisions and can subsequently improve outcomes. We hypothesized that there is evidence about the significance of predictors of outcome not being considered in the decision making process in the treatment of hip fractures because many surgeons are unaware of it. We surveyed 298 North American and European orthopedic surgeons to examine their training and experience and their opinion on the relative importance of predictors of outcome of femoral neck fracture treatment. We compared the results with the highest level of therapeutic and prognostic evidence currently available. Surgeons' perceptions about the importance of the quality of fracture reduction, patient comorbidities, degree of fracture displacement, dementia, and prefracture walking ability were justified by the current literature. However, we further identified a number of variables deemed unimportant to surgeons that have evidence to support their use in managing patients with hip fractures, including the type of anesthesia as a modifiable variable. In contrast to surgeons' perceptions, the available evidence suggests regional anesthesia is associated with a lower mortality risk than general anesthesia.

Entities:  

Mesh:

Year:  2009        PMID: 19388614

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  8 in total

1.  Dedicated orthogeriatric service reduces hip fracture mortality.

Authors:  C Y Henderson; E Shanahan; A Butler; B Lenehan; M O'Connor; D Lyons; J P Ryan
Journal:  Ir J Med Sci       Date:  2016-04-08       Impact factor: 1.568

Review 2.  Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter?

Authors:  T J Luger; C Kammerlander; M Gosch; M F Luger; U Kammerlander-Knauer; T Roth; J Kreutziger
Journal:  Osteoporos Int       Date:  2010-11-06       Impact factor: 4.507

3.  Treatment of femoral neck fractures in elderly patients over 60 years of age - which is the ideal modality of primary joint replacement?

Authors:  Christian Ossendorf; Max J Scheyerer; Guido A Wanner; Hans-Peter Simmen; Clément Ml Werner
Journal:  Patient Saf Surg       Date:  2010-10-20

4.  [Anesthesiological care in orthogeriatric co-management. Perioperative treatment of geriatric trauma patients].

Authors:  Thomas J Luger; Markus F Luger
Journal:  Z Gerontol Geriatr       Date:  2016-04-18       Impact factor: 1.281

5.  Clinical and functional outcomes of internal fixation with intertrochanteric antegrade nail in older patients with proximal extracapsular femoral fractures.

Authors:  M Galli; V Ciriello; L Bocchino; N M Gangemi; M Peruzzi; E Marzetti
Journal:  Eur J Trauma Emerg Surg       Date:  2013-10-17       Impact factor: 3.693

6.  Surgical preferences of patients at risk of hip fractures: hemiarthroplasty versus total hip arthroplasty.

Authors:  Noor Alolabi; Bashar Alolabi; Raman Mundi; Paul J Karanicolas; Jonathan D Adachi; Mohit Bhandari
Journal:  BMC Musculoskelet Disord       Date:  2011-12-23       Impact factor: 2.362

7.  Postoperative Delirium in Elderly Patients Undergoing Hip Fracture Surgery in the Sugammadex Era: A Retrospective Study.

Authors:  Chung-Sik Oh; Ka Young Rhee; Tae-Gyoon Yoon; Nam-Sik Woo; Seung Wan Hong; Seong-Hyop Kim
Journal:  Biomed Res Int       Date:  2016-02-22       Impact factor: 3.411

8.  Early postoperative delirium after hemiarthroplasty in elderly patients aged over 70 years with displaced femoral neck fracture.

Authors:  Yi-Hwa Choi; Dae-Hwan Kim; Tae-Young Kim; Tae-Wan Lim; Seok-Woo Kim; Je-Hyun Yoo
Journal:  Clin Interv Aging       Date:  2017-11-06       Impact factor: 4.458

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.